Search
for

    Sort by

    Community Join

    990-1000 / 1000+ results

      community Oral minoxidil - how important is dermastamping?

      in Microneedling 7 months ago
      A trans woman is using 10 mg oral minoxidil, dutasteride, and estradiol for hair regrowth and is also doing dermastamping despite the pain. Users discuss the benefits of dermastamping for serum absorption and hair follicle stimulation, with some expressing surprise at the high minoxidil dosage.

      community 21M 9 months of 1mg Fin/2.5 Min

      in Finasteride/Dutasteride  25 upvotes 1 year ago
      A 21-year-old has been using 1mg finasteride and 2.5% minoxidil for 9 months with some improvement in hair density. They plan to add collagen, 1% ketoconazole shampoo, and biweekly microneedling to their routine.

      community Losing ground after over 5 years on dutasteride and min

      in Minoxidil  1 upvotes 9 months ago
      The user is experiencing diffuse hair thinning despite using dutasteride and minoxidil for over five years and is considering adding oral minoxidil, microneedling, and nizoral to their regimen. They are concerned about the effectiveness and side effects of these treatments, especially with an upcoming event.

      community Taking only dutasteride and topical redensyl

      in Finasteride/Dutasteride  4 upvotes 1 year ago
      A 27-year-old male with Norwood grade 5 hair loss is using dutasteride and a hair serum with Redensyl, Anagain, Procapil, and Capilia Longa, but is hesitant to use oral minoxidil due to past allergic reactions to topical minoxidil. He plans to try dutasteride alone for 3 months before considering adding oral minoxidil.

      community European release of clascoterone

      in Research/Science  13 upvotes 1 month ago
      Clascoterone's European release is expected in Q4 2026, with FDA approval anticipated by mid-2027. The discussion includes questions about the approval timeline and potential acceleration due to unmet needs.

      community Kintor Pharmaceutical Announces AR-PROTAC (GT20029) Approved for Acne and Androgenic Alopecia Clinical Trials in China

      in Technology  13 upvotes 5 years ago
      The conversation discusses the approval of Kintor Pharmaceutical's AR-PROTAC (GT20029) for clinical trials in China for acne and androgenic alopecia. One user expresses optimism about new treatments being developed and seeks clarification on how the new drug works, specifically if it temporarily degrades the AR protein to reduce DHT sensitivity in hair follicles.

      community Oral 1mg Finesteride 2mg Minoxidil

      in Chat  363 upvotes 3 weeks ago
      The user experienced significant hair regrowth using 1mg finasteride and 2mg minoxidil daily, along with Nizoral shampoo and rosemary oil. They are curious about further improving hair density and whether increasing the minoxidil dose would help.